Updates in Vaccines, Viral Therapy and Non-Lymphocytic Immunotherapy for Glioblastoma

Abstract

A key focus of glioblastoma (GBM) management presently revolves around the cancer’s ability to evade and suppress anti-tumor immune response. Therefore, cancer immunotherapy is a critical area in development and investigation with numerous ongoing clinical trials and animal studies. Ranging from vaccines containing tumor-associated antigens or antigen-presenting dendritic cells to viral therapies and immune checkpoint inhibitor antibodies, immunotherapy offers novel therapeutic avenues for GBM as well as other solid and hematogenous cancers. This review provides an overview and update on various significant immunotherapy developments in addition to introducing novel targets for cancer treatment.

Authors and Affiliations

Adela Wu

Keywords

Related Articles

Integrated Natural Medicine with Modern Medicine: A Concept to Fulfill the Primary Health Care Need in Developing Countries

Integrated Natural Medicine with Modern Medicine: A Concept to Fulfill the Primary Health Care Need in Developing Countries

ErbB Targeted Therapy in Endometrial Cancer

The potential role of ErbB receptors (especially EGFR and ErbB-2) as targets for cancer therapy has been investigated for over 30 years. Anti-ErbB monoclonal antibodies (MoAbs) bind to the extracellular domain of EGFR or...

Current Treatment Approach of Endometrial Cancer

Systematic surgical staging is the primary treatment, for most patients with endometrial cancer and includes: total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy and complete resec...

Early And Long Term Outcomes Of Aortic Valve Surgery Combined Or Not With Cabg Surgery

Objective: The number of patients doing aortic valve surgery with or without CABG (Coronary Artery Bypass Graft) is increasing continuously in our country. The goal of this study is to evaluate the early and long-term re...

A Review on Adverse Health Effects of Laboratory Volatile Solvents

The main objective of this review is to describe the health effects of commonly used laboratory volatile solvents in institutional laboratories. The most commonly used laboratory solvents such as petroleum ether, methano...

Download PDF file
  • EP ID EP202976
  • DOI 10.19070/2332-2926-1600023
  • Views 148
  • Downloads 0

How To Cite

Adela Wu (2016). Updates in Vaccines, Viral Therapy and Non-Lymphocytic Immunotherapy for Glioblastoma. International Journal of Clinical Therapeutics and Diagnosis (IJCTD), 4(3), 117-123. https://europub.co.uk./articles/-A-202976